Oct 28, 202616 minS1
How should clinicians approach metastatic triple-negative breast cancer (mTNBC) when a patient's treatment history does not align with the populations studied in clinical trials? In this episode of The Nuance in mTNBC...
About this Podcast:
The FLASCO OncoPod is a podcast series that brings you engaging interviews and conversations with oncology champions and thought leaders. Each episode explores important topics in cancer care, from the latest clinical advancements to FLASCO events and initiatives. Whether it’s discussing groundbreaking research, policy updates, or sharing personal stories from members, the OncoPod keeps oncology professionals informed and connected. It’s your go-to source for staying up-to-date on FLASCO’s efforts to support and strengthen the oncology community across Florida.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
30%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for FLASCO OncoPod.
Signup to Generate a PitchQuestions about FLASCO OncoPod
What is FLASCO OncoPod about?
The FLASCO OncoPod is a podcast series that brings you engaging interviews and conversations with oncology champions and thought leaders. Each episode explores important topics in cancer care, from the latest clinical advancements to FLASCO events and initiatives. Whether it’s discussing groundbreaking research, policy updates, or sharing personal stories from members, the OncoPod keeps oncology professionals informed and connected.
What has FLASCO OncoPod covered recently?
Recent episodes include "The Nuance in mTNBC | Part 2: The Patient the Trial Did Not Enroll" (28 October 2026, 16 minutes), "The Nuance in mTNBC | Part 1: Where the Answers Split" (20 October 2026, 16 minutes), and "Drew Piers on Advocacy, Storytelling & Shaping the Future of Cancer Care" (3 August 2026, 23 minutes).
How often does FLASCO OncoPod publish?
FLASCO OncoPod publishes roughly weekly, with episodes averaging 19 minutes across 35 episodes.
How hard is it to get booked on FLASCO OncoPod?
Booking probability for FLASCO OncoPod is 30%, and the host is rated Selective on guests. FLASCO OncoPod requires a Pod Score of 80 or higher. FLASCO OncoPod's contact route on record: public web form.
Who should pitch FLASCO OncoPod?
The strongest fits for FLASCO OncoPod are Health & Wellness Services and Hospitals. FLASCO OncoPod has a business audience.
About the host
FLASCO OncoPod is a business podcast with 35 episodes published.
Host email not verified for this podcastSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Oct 20, 202616 minS1Treatment decisions in metastatic triple-negative breast cancer (mTNBC) are becoming increasingly complex as new therapeutic options reshape the first-line landscape. In this episode of The Nuance in mTNBC, Dr. Edgardo...
Aug 3, 202623 minS1In this episode of the FLASCO OncoPod, Drew Piers, President of Sachs Media, explores the powerful role advocacy, storytelling, and strategic communications play in advancing cancer care beyond the clinic. Drawing on...
FLASCO OncoPod
The Evolving Management of Hepatocellular Carcinoma: Prevention, Multidisciplinary Care, and Emerging Therapies
Jul 27, 202629 minHepatocellular carcinoma (HCC) continues to present unique challenges for oncology teams, requiring coordinated multidisciplinary care and an evolving understanding of both liver disease and cancer management. In this...
Episode #31
The Evolving Role of Community Oncology: Delivering Academic-Level Cancer Care Close to Home
Jul 20, 202622 minS1In this episode of the FLASCO OncoPod, Dr. McDonough moderates a discussion with Dr. Wenk, Dr. Glick, and Dr. Patel, of Florida Cancer Specialists & Research Institute on the evolving role of community oncology and how...
View More
Jul 20, 202620 minS1In this episode of the FLASCO OncoPod, host Dr. Edgardo Santos, President of the Florida Society of Clinical Oncology (FLASCO), leads a multidisciplinary discussion on the evolving role of immunohistochemistry (IHC) in...
Jul 16, 202615 minS1In this episode of the FLASCO OncoPod, host Dr. Edgardo Santos , President of the Florida Society of Clinical Oncology (FLASCO), leads a multidisciplinary discussion on the evolving role of immunohistochemistry (IHC) in...
Jul 16, 202616 minS1In this episode of the FLASCO OncoPod, host Dr. Edgardo Santos , President of the Florida Society of Clinical Oncology (FLASCO), leads a multidisciplinary discussion on the evolving role of immunohistochemistry (IHC) in...
Jul 13, 202619 minS1In this episode of the FLASCO OncoPod, host Dr. Edgardo Santos , President of the Florida Society of Clinical Oncology (FLASCO), leads a multidisciplinary discussion on the evolving role of immunohistochemistry (IHC) in...
Jun 5, 202628 minS1<p>The treatment landscape for chronic lymphocytic leukemia (CLL) has transformed dramatically over the past decade, creating new opportunities and new questions for clinicians managing this increasingly complex...
Jun 2, 202618 minS1<p>Join Scott E. Jordan, MD, FACOG, gynecologic oncologist at Broward Health, as he breaks down the most important endometrial cancer updates presented at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting...
May 11, 202614 minS1<p>What does it take to successfully navigate the business of oncology while continuing to deliver exceptional patient care?</p><p>In this episode of the FLASCO OncoPod, Dr. Robin Zon joins Dr. Jorge Garcia for a...
May 1, 20268 minS1<p>In this final episode of the FLASCO OncoPod series, Drs. Jaglal, Fu, and Shahzad shift focus to the long-term management of atypical hemolytic uremic syndrome (aHUS) in oncology patients.</p><p>Building on the...
May 1, 202611 minS1<p>In this episode of the FLASCO OncoPod, Drs. Jaglal, Fu, and Shahzad explore the real-world challenges of managing suspected thrombotic microangiopathy (TMA) in oncology patients.</p><p>Building on a complex multiple...
Apr 21, 20267 minS1<p>Atypical hemolytic uremic syndrome (aHUS) in patients with malignancy or undergoing cancer-directed therapy is likely under-recognized, yet early identification can have a profound impact on patient...
Mar 30, 202618 minS1<p>Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals, alongside Dr. Noman Ashraf, MD, of Tampa General Hospital Cancer Institute for the final installment of the...
Mar 18, 202620 minS1<p>Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals, alongside Dr. Noman Ashraf of Tampa General Hospital Cancer Institute and Dr. Umair Majeed of Mayo Clinic in...
Episode #18
Advancing Care in GI and Biliary Tract Cancers Series Episode 2: HER2 Testing in BTC and GEA
Mar 12, 202622 minS1<p>Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals, alongside Dr. Paresh Patel and Dr. Masoumeh Ghayouri for the second installment of the Advancing Care in GI...
Mar 3, 202626 minS1<p>Join moderator Caroline DiCristo, PharmD, Associate Medical Director – Zanidatamab of Jazz Pharmaceuticals and GI Oncologist Dr. Umair Majeed of Mayo Clinic in Jacksonville for the first installment of the Advancing...
Feb 20, 202629 minS1<p>Join Dr. Edgardo Santos and Dr. Luis Raez for a practical discussion on first-line decision-making in EGFR-mutated lung cancer and how early treatment choices shape survival, sequencing, and patient...
Recent guests
Recent guests on FLASCO OncoPod. Study who booked and why before you pitch.
D
Dr. Robin Zon
Vice President and Senior Partner, American Society of Clinical Oncology
D
Dr. Jorge Garcia
vereador da Cultura, Case Western Reserve University School of Medicine
D
Dr. Luis Raez
investigator in cancer and professor of hematology and medical oncology, Memorial Cancer Institute of Florida Atlantic University
N
Neil M. Iyengar
associate professor and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at Emory University School of Medicine, Winship Cancer Institute at Emory University
Best industries to pitch FLASCO OncoPod for
PitchCentric classifies FLASCO OncoPod under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
OncTimes Talk
28~400 listeners88% similar
The ONS Podcast
37~529 listeners87% similar
CancerSpeak: An American Cancer Society Journals Podcast
20~286 listeners87% similar
ASCO Daily News
28~400 listeners87% similar
Neuro-Oncology: The Podcast
31~446 listeners87% similar
Liver Cancer Podcast
20~292 listeners87% similar
Podcasts like FLASCO OncoPod
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ